AMTI
- Applied Molecular Transport Inc.
()
Overview
Company Summary
Applied Molecular Transport Inc. (AMTI) is a biopharmaceutical company focused on revolutionizing drug delivery and treatment options. The company specializes in developing innovative therapies by harnessing the power of transporters, which are naturally occurring proteins that play a crucial role in the movement of molecules in our bodies.
Unlike traditional drugs that only target specific receptors on the surface of cells, AMTI's approach involves designing and developing therapeutic candidates that can interact with transporters to gain access to internal cellular compartments. By utilizing the transporter-mediated approach, AMTI aims to enhance the delivery and efficacy of drugs, potentially leading to improved patient outcomes.
The company's proprietary technology platform allows them to identify and select specific transporters that can efficiently transport a wide range of drugs across biological barriers, such as the intestinal epithelium or the blood-brain barrier. This capability is particularly valuable for treating diseases that require targeted delivery to specific tissues or organs.
AMTI's research and development efforts span multiple therapeutic areas, including immunology, gastroenterology, and neurology. They are actively working on developing pipeline products to address conditions like inflammatory bowel disease, autoimmune disorders, and neurological disorders.
In addition to their drug discovery and development activities, AMTI collaborates with strategic partners, including pharmaceutical companies and academic institutions, to advance their scientific knowledge and bring promising therapies to market more effectively.
Overall, Applied Molecular Transport Inc. leverages transporter technology to create novel drug delivery solutions, aiming to transform the way diseases are treated and managed.